Results

Total Results: 923 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

401. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
     April 15, 2021 - As with the abstract, it would be helpful to note whether these findings apply to patients treated … although no head-to-head trials of lithium and valproic acid are available, data from other studies and patient … The phrase “reduced use of safety and child development practices” is unclear. … well-being, depressive symptoms are associated with adverse parenting practices such as reduced use of safety … We added a note about risk factors being more common among psychiatric patients.

402. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Potential Patient and Clinical Staff Safety Issues 17. … Patient Safety Issues (if applicable) 15. Required Resources 16. … data from conferences or published articles reporting different results or confirming efficacy and safety … Safety data that could change perspectives c. … Has a patient safety alert been issued that could signal a safety/efficacy change in perspectives?

403. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - Additional scrutiny regarding the safety of teduglutide and its impact on cost of care is likely going … Patients who experience toxicity require hospitalization and corticosteroid infusion. 10 If the patient … thorough patient education practices. … During the followup period (up to 25 months) no patient reported dysphagia recurrence, but some patients … These malignancies were reviewed by an independent safety review board that requested no changes to

404. Effectiveness of Treatments for Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
     May 09, 2016 - neuropathy increases risk for foot injury, delayed treatment (since injuries are not noticed by the patient … therapeutic footwear with demonstrated pressure-relieving effect that is consistently worn by the patient … addressed all causes of peripheral neuropathy and recommended a number of agents and also included a safety … Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. … Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain

405. Cervical Degenerative Disease Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
     January 12, 2022 - , motor evoked potential measurements, spontaneous and triggered electromyography) may improve the safety … We will also assess how effectiveness and harms may differ by patient and disease characteristics (e.g … age, duration of symptoms, and MRI T2 hyperintensity as prognostic indicators; and the identification … Preventive Services Task Force34 and will include methods of patient selection (e.g., consecutive patients … Efficacy and safety of total disc replacement compared with anterior cervical discectomy and fusion

406. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - Do these harms differ according to patient subgroup characteristics, including but not limited to HCV … Do these harms differ according to patient subgroup characteristics, including but not limited to HCV … Do these harms differ according to patient subgroup characteristics? … treated with pegylated interferons in Georgia Long-term SVR according to patient characteristics … , Efficacy and Pharmacokinetics of BI 201335 NA in Patient With Genotype 1 Chronic Hepatitis C

407. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Input and comments from the public, including patients and patient representatives, was solicited … generalize conclusions concerning opioid safety or effectiveness, Research Gaps to note this as a … for that specific patient. … Brian Callahan / 22 National Safety Council Evidence Summary See attached document The systematic … Everything has risk and that should be outlined to the patient as well.

408. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
     November 27, 2017 - Kind regards, Alan Goldberg, RPh Senior Director, Product Safety and Medical Services Thank you … National EMS Scope of Practice Model, a document published by the National Highway Transportation Safety … care and safety. … care, assessment, and safety is demonstrated. … The lack of evidence is also reported clearly regarding the safety of releasing opiate overdose patients

409. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - We describe the accuracy, potential benefits, and potential risks of each modality, including safety … • What are the advantages, disadvantages, safety issues and relative costs of each modality? … Both Key Informant patient advocates reported that patients receive intangible value from receiving … Both patient advocates also reported that breast cancer patients are generally not concerned about the … The most commonly used radiotracer for bone scans is technetium-99m.26 Safety issues pertaining to bone

410. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - • Population(s): - For KQ1, all patients with, or at risk for, osteoporotic fractures (or who meet … - Subgroups of patients are considered in KQ2. … Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety- RelatedDrugLabelingChanges … /MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm122109.htm� http://www.fda.gov/Safety … /MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm122109.htm� http://www.fda.gov/Safety

411. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
     June 28, 2013 - Response TEP #7 General Although I agree in principle that evidence gaps are present and are compare to safety … cardioversion is clearly more effective; the real key question is the comparative effectiveness and safety … Out recommendation is that Key Question 5 includes an emphasis on patient centered outcomes. … Specifically we recommend the following specific text: What are the comparative safety and effectiveness … Does the comparative safety and effectiveness of these therapies differ among specific patient subgroups

412. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
     September 01, 2007 - safety system. 4. … with the patients consent. … For patients who are not already in the system, a basic patient information questionnaire is used to … For example, CVS required the patients to give their categorical affirmative response before patient … Menachemi N, Burke D, Brooks RG. (2004) "Adoption factors associated with patient safety-related information

413. Cover Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
     September 01, 2007 - safety system. 4. … with the patients consent. … For patients who are not already in the system, a basic patient information questionnaire is used to … For example, CVS required the patients to give their categorical affirmative response before patient … Menachemi N, Burke D, Brooks RG. (2004) "Adoption factors associated with patient safety-related information

414. Topic-Brief2-Opioid-Withdrawal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
     April 01, 2021 - Human Services guide on tapering recommends that clinicians review goals of opioid therapy with the patient … (based on setting and patient population), and focusing on effects of tapering on pain severity and … Department of Health and Human Services Working Group on Patient- Centered Reduction or Discontinuation … policy recommendations from the VHA State-of- the-Art Conference on Strategies to Improve Opioid Safety … Patient-centered prescription opioid tapering in community outpatients with chronic pain.

415. Topic-Brief2-Opioid-Withdrawal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
     April 01, 2021 - Human Services guide on tapering recommends that clinicians review goals of opioid therapy with the patient … (based on setting and patient population), and focusing on effects of tapering on pain severity and … Department of Health and Human Services Working Group on Patient- Centered Reduction or Discontinuation … policy recommendations from the VHA State-of- the-Art Conference on Strategies to Improve Opioid Safety … Patient-centered prescription opioid tapering in community outpatients with chronic pain.

416. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - therefore, have a strong impact on the choice of the drug for second-line combination therapy in a patient … factors, as suggested in recent guidelines.4 These include clinical factors such as patient age and … Finally, we did not evaluate patient-reported outcomes, such as quality of life; future research is … needed to identify ideal measures to assess treatment-sensitive patient-reported outcomes in diabetes … Patient preferences for noninsulin diabetes medications: a systematic review.

417. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - of the included studies specifically inclusive of nursing facility residents and if so, likely a Patient … could fully control for channeling that can occur (preferential selection of antidepressants based on patient … Efficacy ad safety of antidepressants for treatment of depression in Alzheimer’s disease: a metaanalysis … knowing the likelihood that an adverse effect will occur for a particular patient or with a typical … #5 Discussion P. 38, “Conclusions,” 2nd sentence: “Further characterization of the comparative safety

418. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - statin therapy with another lipid-modifying agent could be an alternative provided short and long-term safety … b) "…safety and efficacy are established with evidence." … (54%) reported an AE (39 patients on ezetimibe, 34 patients on fluvastatin XL, and 34 patients on fluvastatin … Safety of aggressive lipid management. J Am Coll Cardiol, 2007; 49(17):1753-62). … Every patient?s last observed value will be used in the primary analysis."

419. Antiplatelet-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
     September 01, 2013 - However, patient response to clopidogrel-based antiplatelet therapy is variable both between patients … and across multiple measurements within a patient, with some patients showing no or minimal platelet … GRAVITAS multicenter trial (Gauging Responsiveness with a VerifyNow Assay—Impact on Thrombosis and Safety … studies compared the effect of alternative treatment strategies, stratified by CYP2C19 genotype, on safety … Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and

420. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - Anticipated Cost Per Patient (if known) 11. … Potential Patient and Clinical Staff Safety Issues 14. … Patient Safety Issues (if applicable) 11. Required Resources 12. … Safety data that could change perspectives 4. … A patient safety alert been issued that could signal a safety/efficacy change in perspectives?